Michael Scheurer, PhD, MPH, FACE
Picture
Michael Scheurer, PhD, MPH, FACE
Professor
Positions
- Professor
-
Pediatrics
Hematology-Oncology
草榴社区入口
Houston, Texas United States
- Adjunct Professor
-
University of Texas School of Public Health
- Director, Population Sciences Biorepository
-
Dan L Duncan Comprehensive Cancer Center
草榴社区入口
Houston, Texas United States
- Director
-
Research and Tissue Support Services Core
Texas Children's Hospital
- Director
-
Center for Epidemiology & Population Health
草榴社区入口
- Associate Director for Inclusive Leadership and Culture
-
Dan L Duncan Comprehensive Cancer Center
草榴社区入口
- Sidney L. and Donald F. Faust Chair of Pediatric Cancer Epidemiology
-
Texas Children's Hospital
Addresses
- Pavilion Tower II (Office)
-
Suite 1530.25
Houston, TX 77030
United States
- Feigin Tower (Lab)
-
Suite C1160
Houston, TX 77030
United States
Education
- Post-Doctoral Fellowship at MD Anderson Cancer Center
- 07/2006 - Houston, Texas United States
- Molecular Epidemiology
- MPH from University of Alabama at Birmingham
- 06/1999 - Birmingham, Alabama United States
- Epidemiology
- PhD from University of Texas Health Science Center
- 12/2004 - Houston, Texas United States
- Epidemiology
Professional Statement
Dr. Scheurer is a molecular epidemiologist at Texas Children鈥檚 Cancer Center and in the Cancer Prevention and Population Sciences Program of the Dan L Duncan Comprehensive Cancer Center at 草榴社区入口. He also serves at the Associate Director for Inclusive Leadership and Culture and the Co-Director of the Integrated Biobanking Shared Resource for the Cancer Center and the Director of the Population Sciences Biorepository, an Advanced Technology Core of the College.Dr. Scheurer鈥檚 research focuses on viruses, environmental insults, and immune function as risk factors for cancer development and progression. His laboratory looks for novel ways to identify and catalog molecular markers of these exposures as risk factors for the development of cancer and for risk of adverse outcomes. He is actively involved with two large international research groups focused on two rare tumors: the Brain Tumor Epidemiology Consortium and the Childhood Leukemia International Consortium.
His research also focuses on understanding the factors that are associated with cancer health disparities and working toward interventions to overcome those disparities.
Websites
Selected Publications
- Badr H, Rouce R, Scheurer ME, Lulla P, Mims M, Reddy P "." Cancer Cell. 2023;41(12):2007-2010. Pubmed PMID:
- Winestone LE, Getz KD, Li Y, Burrows E, Scheurer ME, Tam V, Gramatges MM, Wilkes JJ, Miller TP, Seif AE, Rabin KR, Fisher BT, Aplenc R "." Pediatr Blood Cancer. 2024;71(1):e30726. Pubmed PMID:
- Stricker E, Peckham-Gregory EC, Scheurer ME "." Biomedicines. 2023;11(3):936. Pubmed PMID:
- Dharia P, Swartz MD, Bernhardt MB, Chen H, Gramatges MM, Lupo PJ, Brown AL, Scheurer ME "." Leuk Lymphoma. 2022;63(12):2948-2954. Pubmed PMID:
- Brown AL, Sok P, Raghubar KP, Lupo PJ, Richard MA, Morrison AC, Yang JJ, Stewart CF, Okcu MF, Chintagumpala MM, Gajjar A, Kahalley LS, Conklin H, Scheurer ME "." Neuro Oncol. 2023;25(9):1698-1708. Pubmed PMID:
- Shakeel O, Lupo PJ, Strong S, Arora M, Scheurer ME "." Pediatr Hematol Oncol. 2022;39(3):193-202. Pubmed PMID:
- Schraw JM, Petridou ET, Bonaventure A, Dockerty JD, Karalexi M, Ntzani E, Infante-Rivard C, Clavel J, Bracci PM, McKean-Cowdin R, Roman E, Kane E, Erdmann F, Sch眉z J, Mueller BA, Scheurer ME "." Cancer Causes Control. 2023;34(11):1005-1015. Pubmed PMID:
- Hoang TT, Rosales O, Burgess E, Lupo PJ, Scheurer ME, Oluyomi AO "." Toxics. 2023;11(4):351. Pubmed PMID:
- Zobeck M, Bernhardt MB, Kamdar KY, Rabin KR, Lupo PJ, Scheurer ME "." Pharmacotherapy. 2023;43(3):205-214. Pubmed PMID:
- Lupo PJ, Petrick LM, Hoang TT, Janitz AE, Marcotte EL, Schraw JM, Arora M, Scheurer ME "." Bioessays. 2021;43(9):e2100030. Pubmed PMID:
- Schraw JM, Bailey HD, Bonaventure A, Mora AM, Roman E, Mueller BA, Clavel J, Petridou ET, Karalexi M, Ntzani E, Ezzat S, Rashed WM, Marcotte EL, Spector LG, Metayer C, Kang AY, Magnani C, Miligi L, Dockerty JD, Mej委a-Arangur茅 JM, ..., Scheurer ME "." Int J Cancer. 2022;151(7):1013-1023. Pubmed PMID:
- Harris RD, Taylor OA, Raghubar KP, Matheus Gonzalez M, Zobeck M, Gramatges MM, Rabin KR, Scheurer ME, Brown AL "." Pediatr Blood Cancer. 2024;71(9):e31169. Pubmed PMID:
- Harris RD, Bernhardt MB, Zobeck MC, Taylor OA, Gramatges MM, Schafer ES, Lupo PJ, Rabin KR, Scheurer ME, Brown AL "." Cancer. 2023;129(8):1287-1294. Pubmed PMID:
- Williams LA, Haynes D, Sample JM, Lu Z, Hossaini A, McGuinn LA, Hoang TT, Lupo PJ, Scheurer ME "." J Natl Cancer Inst. 2024;116(6):876-884. Pubmed PMID:
- Raghubar KP, Chambers T, Hill RM, Taylor O, Hockenberry M, Hooke MC, Mitby P, Moore IK, Brown AL, Scheurer ME "." Psychooncology. 2022;31(10):1782-1789. Pubmed PMID:
- Brown AL, Raghubar KP, Taylor OA, Bernhardt MB, Kahalley LS, Pan W, Lupo PJ, Hockenberry MJ, Scheurer ME "." Support Care Cancer. 2021;29(5):2455-2464. Pubmed PMID:
- Castellanos MI, Oluyomi AO, Chambers TM, Gramatges MM, Winestone LE, Lupo PJ, Scheurer ME "." Cancer. 2023;129(8):1276-1286. Pubmed PMID:
- Brown AL, Sok P, Taylor O, Woodhouse JP, Bernhardt MB, Raghubar KP, Kahalley LS, Lupo PJ, Hockenberry MJ, Scheurer ME "." J Pain Symptom Manage. 2021;61(3):464-473. Pubmed PMID:
- Vasquez P, Escalante J, Raghubar KP, Kahalley LS, Taylor OA, Moore IK, Hockenberry MJ, Scheurer ME, Brown AL "." Pediatr Blood Cancer. 2022;69(5):e29507. Pubmed PMID:
- Scheurer ME, Zhou R, Gilbert MR, Bondy ML, Sulman EP, Yuan Y, Liu Y, Vera E, Wendland MM, Youssef EF, Stieber VW, Komaki RR, Flickinger JC, Kenyon LC, Robins HI, Hunter GK, Crocker IR, Chao ST, Pugh SL, Armstrong TS "." Neurooncol Adv. 2022;4(1):vdac152. Pubmed PMID:
to edit your profile
